[1] Armelin HA.Pituitary extracts and steroid hormones in the control of 3T3 cell growth[J]. Proc Natl Acad Sci USA, 1973, 70(9): 2702-2706.
[2] Imamura T.Physiological functions and underlying mechanisms of fibroblast growth factor (FGF) family members:recent findings and implications for their pharmacological application[J]. Biol Pharm Bull, 2014, 37(7): 1081-1089.
[3] Lemmon MA, Schlessinger J.Cell signaling by receptor tyrosine kinases[J]. Cell, 2010, 141(7): 1117-1134.
[4] Ornitz DM, Itoh N.The Fibroblast Growth Factor signaling pathway[J]. Wiley Interdiscip Rev Dev Biol, 2015, 4(3): 215-266.
[5] Carpenter G, Ji Q.Phospholipase C-γ as a signal-transducing element[J]. Exp Cell Res, 1999, 253(1): 15-24.
[6] Belov AA, Mohammadi M.Molecular mechanisms of fibroblast growth factor signaling in physiologyand pathology[J]. Cold Spring Harb Perspect Biol, 2013, 5(6): a015958.
[7] Dutt A, Ramos AH, Hammerman PS, et al.Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer[J]. PloS One, 2011, 6(6): e20351.
[8] Weiss J, Sos ML, Seidel D, et al.Frequent and focal FGFR1 am- plification with therapeutically tractable FGFR1 dependency in squamous cell lung cancer[J]. Sci Transl Med, 2010, 2(62): 62-93.
[9] Schlessinger J, Plotnikov AN, Ibrahimi OA, et al.Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization[J]. Mol Cell, 2000, 6(3): 743-750.
[10] Mohammadi M, Olsen SK, Ibrahimi OA.Structural basis for fibroblast growth factor receptor activation[J]. Cytokine Growth Factor Rev, 2005, 16(2): 107-137.
[11] 范洪宽,周慧,李惟. 成纤维细胞生长因子与其受体相互作用及其抑制剂的研究进展[J]. 生物化学与生物物理进展,2001,28(3):338-341.
[12] Hou J, Kan M, Wang F, et al.Substitution of putative half-cystine residues in heparin-binding fibroblast growth factor receptors[J]. J Biol Chem, 1992, 267(25): 17804-17808.
[13] 许英蕾,孙建义. 成纤维细胞生长因子与其受体的研究进展[J]. 药物生物技术,2004,11(3):194-198.
[14] Plotnikov AN, Schlessinger J, Hubbard SR, et al.Structural basis for FGF receptor dimerization and activation[J]. Cell, 1999, 98(5): 641-650.
[15] Wang F, Kan M, McKeehan K, et al. A homeo-interaction sequence in the ectodomain of the fibroblast growth factor receptor[J]. J Biol Chem, 1997, 272(38): 23887-23895.
[16] Knights V, Cook SJ.De-regulated FGF receptors as therapeutic targets in cancer[J]. Pharmacol Ther, 2010, 125(1): 105-117.
[17] Wiedemann M, Trueb B.Characterization of a Novel Protein (FGFRL1) from Human Cartilage Related to FGF Receptors[J]. Genomics, 2000, 69(2): 275-279.
[18] Stachowiak MK, Maher PA, Stachowiak EK.Integrative nuclear signaling in cell development-a role for FGF receptor-1[J]. DNA Cell Biol, 2007, 26(12): 811-826.
[19] 赵军伟,李争争,孟会强,等. 成纤维细胞生长因子受体3在骨重建中作用机制的研究进展[J]. 实用临床医学,2016,17(4):94-97.
[20] 梁鑫,王萍. 成纤维细胞生长因子及其受体在牙齿生长发育中的作用[J]. 口腔医学研究,2016,32(4):421-423.
[21] 李靖,杨俐萍. 成纤维细胞生长因子受体5的研究进展[J]. 中国肿瘤生物治疗杂志,2017,24(2):201-205.
[22] 陈鹏,张凡喜,周玉峰,等. p38信号通路在成纤维细胞生长因子受体2持续增强对软骨内成骨过程的影响[J]. 中华实验外科杂志,2014,31(7):1402-1405.
[23] Blanc SL, Simann M.Fibroblast growth factors 1 and 2 inhibit adipogenesis of human bone marrow stromal cells in 3D collagen gels[J]. Exp Cell Res, 2015, 338(2): 136-148.
[24] Gerber SD, Beauchamp P, Zhuang L, et al.Functional domains of the FgfrL1 receptor[J]. Dev Biol, 2020, 461(1): 43-54.
[25] Choi CH, Chung JY, Kim JH, et al.Expression of fibroblast growth factor receptor family members is associated with prognosis in earli stage cervical cancer patients[J]. J Transl Med, 2016, 14(1): 124.
[26] Helsten T, Elkin S, Arthur E, et al.The FGFR landscape in cancer:analysis of 4,853 tumors by next-generation sequencing[J]. Clin Cancer Res, 2016, 22(1): 259-267.
[27] 王明,孙震宇,黄礼年. FGF/FGFR信号通路在肺鳞癌靶向治疗中的研究进展[J]. 肿瘤防治研究,2016,43(7):638-644.
[28] Wu YM, Su F, Kalyana-Sundarams, et al.Identification of targetable FGFR gene fusions in diverse cancers[J]. Cancer Discov, 2013, 3(6): 636-647.
[29] Sia D, Losic B.Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma[J]. Nat Commun, 2015, 6: 6087.
[30] Robertson AG, Kim J, Al-Ahmadie H, et al.Comprehensive molecular characterization of muscle-invasive bladder cancer[J]. Cell, 2017, 171(3): 540-556.
[31] 石超吉,周榕,韩永. 成纤维细胞生长因子受体家族在头颈鳞癌细胞中的表达及定位[J]. 上海口腔医学,2016,25(5):517-521.
[32] Loriot Y, Necchi A,Park SH, et al.Erdafitinib in locally advanced or metastatic urothelial carcinoma[J]. N Engl J Med, 2019, 381(4): 338-348. |
